Ocular pemphigoid and Visual acuity reduced

Summary:

Visual acuity reduced is found among people with Ocular pemphigoid, especially for people who are female, 60+ old.

The study analyzes which people have Visual acuity reduced with Ocular pemphigoid. It is created by eHealthMe based on reports of 23 people who have Ocular pemphigoid from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Ocular pemphigoid?

Ocular pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye) is found to be associated with 15 drugs and 41 conditions by eHealthMe. Check the latest studies of Ocular pemphigoid.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,492 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.



On Jul, 20, 2026

23 people who have Ocular Pemphigoid and Visual Acuity Reduced are studied.

Would you have Visual acuity reduced when you have Ocular pemphigoid?

Gender of people who have Ocular Pemphigoid and experienced Visual Acuity Reduced *:

  • female: 56.25 %
  • male: 43.75 %

Age of people who have Ocular Pemphigoid and experienced Visual Acuity Reduced *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Pemphigoid (tense blisters on the skin): 7 people, 30.43%
  2. Eye Inflammation: 6 people, 26.09%
  3. Stable Angina (a constant chest pain): 1 person, 4.35%
  4. Myocarditis (inflammation of heart muscle myocardium): 1 person, 4.35%
  5. High Blood Pressure: 1 person, 4.35%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.35%

Common drugs taken by these people *:

  1. Restasis: 17 people, 73.91%
  2. Myfortic: 16 people, 69.57%
  3. Tobradex: 14 people, 60.87%
  4. Cellcept: 10 people, 43.48%
  5. Rituxan: 9 people, 39.13%
  6. Prednisone: 9 people, 39.13%
  7. Doxycycline: 9 people, 39.13%
  8. Lumigan: 8 people, 34.78%
  9. Breo Ellipta: 8 people, 34.78%
  10. Escitalopram: 8 people, 34.78%

Common symptoms for these people *:

  1. Eye Pain: 9 people, 39.13%
  2. Rhinalgia (pain in the nose): 9 people, 39.13%
  3. Cataract (clouding of the lens inside the eye): 9 people, 39.13%
  4. Depression: 9 people, 39.13%
  5. Pain: 9 people, 39.13%
  6. White Blood Cell Count Decreased: 9 people, 39.13%
  7. Conjunctival Scar (conjunctival scarring): 9 people, 39.13%
  8. Weight Increased: 9 people, 39.13%
  9. Eye Inflammation: 9 people, 39.13%
  10. Disease Progression: 8 people, 34.78%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Visual acuity reduced:

All the conditions that are associated with Visual acuity reduced:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Visual acuity reduced and Ocular pemphigoid, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: